{"id":"W3209833176","doi":"10.1186/s12885-021-08746-z","title":"Cost-effectiveness analysis of first-line treatment with crizotinib in ROS1-rearranged advanced non-small cell lung cancer (NSCLC) in Canada","year":2021,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Kingston General Hospital; Grand River Hospital; Canadian Centre for Applied Research in Cancer Control; Sunnybrook Health Science Centre; Cancer Care Ontario","funders":"Cancer Care Ontario","keywords":"Crizotinib; Medicine; Oncology; Lung cancer; ROS1; Internal medicine; ALK inhibitor; Quality-adjusted life year; Cost effectiveness; Cancer; Adenocarcinoma","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002470955,0.0008614345,0.001229067,0.001413778,0.0008428564,0.001766552,0.001616631,0.0008021165,0.002782851],"category_scores_gemma":[0.008464135,0.0006307503,0.002454235,0.002180324,0.0007000761,0.000513424,0.0007752628,0.001085822,0.0001322793],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.09856162,"about_ca_system_score_gemma":0.07542205,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9716867,"about_ca_topic_score_gemma":0.9545178,"domain_scores_codex":[0.9984871,0.0005010584,0.00007176841,0.0001621344,0.000374154,0.0004037533],"domain_scores_gemma":[0.997112,0.001256198,0.000401227,0.00006701676,0.000750657,0.0004128888],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","study_design_scores_codex":[0.004339834,0.0003108806,0.05343246,0.001349885,0.002238221,0.0005313628,0.0001373487,0.8979333,0.0006456824,0.007530954,0.004854683,0.02669542],"study_design_scores_gemma":[0.002447684,0.001476322,0.08571542,0.0006503341,0.003507369,0.0005598512,0.0005685199,0.8930309,0.0008817171,0.003909532,0.00706169,0.0001906377],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.938965,0.0154256,0.006708764,0.005081479,0.00009730402,0.001154672,0.01735219,0.000134118,0.01508085],"genre_scores_gemma":[0.9926812,0.002285361,0.002023971,0.0001796767,0.00001091615,0.00009550936,0.001893376,0.00001201121,0.0008181161],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09856162,"threshold_uncertainty_score":0.7151179,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02630918868941176,"score_gpt":0.3413162003380924,"score_spread":0.3150070116486806,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}